| Literature DB >> 30258979 |
Kristopher Kow1, Timothy James Watson1, David Foo1, Hee Hwa Ho1.
Abstract
BACKGROUND: There is limited data on the natural history of Takotsubo (stress-induced) cardiomyopathy in South-East Asian patients. We aim to evaluate the clinical characteristics, predisposing factors and outcomes of patients diagnosed with Takotsubo cardiomyopathy in our region.Entities:
Keywords: Cardiomyopathy; Complications; Outcome; Risk factor; South-East Asia; Stress-induced
Year: 2018 PMID: 30258979 PMCID: PMC6154765 DOI: 10.1016/j.ijcha.2018.09.007
Source DB: PubMed Journal: Int J Cardiol Heart Vasc ISSN: 2352-9067
Baseline clinical characteristics of patients with Takotsubo cardiomyopathy.
| N = 98 | |
|---|---|
| Female sex, n, % | 80 (82) |
| Age, years | 69.3 ± 12.6 |
| Antecedent trigger, n,% | |
| Physical | 46 (47) |
| Emotional | 16 (16.3) |
| No evident trigger | 34 (35) |
| Chest pain, n, % | 52 (53.1) |
| Dyspnea, n, % | 44 (45) |
| Diaphoresis, n, % | 18 (18.5) |
| Body mass index, kg/m2 | 23.9 ± 5.5 |
| Systolic blood pressure, mmHg | 125.5 ± 34.2 |
| Median troponin I, μg/L, (range) | 4.6 (1–90) |
| Median brain natriuretic peptide, pg/mL, (range) | 571 (102–3531) |
| ST segment changes, n, % | |
| Elevation | 65(66.3) |
| Depression | 6(6.1) |
| T wave inversion | 18(18.4) |
| LVEF at presentation - % | 35 ± 11 |
| Underlying medical condition, n, % | |
| Coronary artery disease (obstructive) | 17(17.3) |
| Neurologic disorder | 24 (24.5) |
| Psychiatric disorder | 4 (4.1) |
LVEF: left ventricular ejection fraction.
Types of Takotsubo Cardiomyopathy and In-hospital Outcomes.
| N = 98 | |
|---|---|
| Takotsubo cardiomyopathy subtypes, n, % | |
| Apical | 87 (89) |
| Basal (inverted Takotsubo) | 3 (3.1) |
| Midventricular | 5 (5.1) |
| Focal | 2 (2.0) |
| Others (undefined) | 1 (1.0) |
| Treatment, n, % | |
| Catecholamine | 28 (28.6) |
| Invasive or noninvasive ventilation | 30 (30.6) |
| Cardiopulmonary resuscitation | 8 (8.2) |
| In-hospital outcomes, n, % | |
| Cardiogenic shock | 10 (10.2) |
| Death due to any cause | 11 (11.2) |
| Death due to cardiovascular cause | 4 (4.1) |
| In-hospital Complications, n, % | 37 (38) |
| Median length of hospital stay, days, (range) | 6 (1–88) |
| Type of medications, n, % | |
| Beta-blockers | 58 (59.2) |
| Angiotensin-converting enzymes inhibitors/Angiotensin-receptor blockers | 45 (46) |
| Anti-platelet therapy | 61/(62) |
Predictors of in-hospital complications.
| Factor(s) | Hazard ratio | p value |
|---|---|---|
| Male gender | 2.2 | 0.25 |
| Physical stressor | 2.1 | 0.16 |
| Emotional stressor | 0.2 | 0.1 |
| Smoking history | 3.1 | 0.09 |
| Lower LVEF (<35%) | 5.35 | 0.001 |
p value <0.05.